Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 2, 1997, Pages 115-120

  Ostrow, Michelle J ^a   Cornelisse, Peter G A ^a   Heath, Katherine V ^a,b   Craib, Kevin J P ^a   Schechter, Martin T ^a,b   O'Shaughnessy, Michael ^a,b   Montaner, Julio S G ^a,b   Hogg, Robert S ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

AIDS; Canada; Complementary therapy use; HIV infections

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CANADA; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030743962     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199706010-00003     Document Type: Article

References (18)

1. Hand R. Alternative therapies used by patients with AIDS. N Engl J Med 1989;12:672-3.
2. Steinberg C. Integrating traditional medicine with other therapies in the treatment of HIV-infected individuals. Md Med J 1990;39: 183-8.
3. Abrams D. Alternative therapies in HIV infection. AIDS 1990;4: 1179-87.
4. Greenblatt RM, Hollander H, McMaster JR, Henke CJ. Polypharmacy among patients attending an AIDS clinic. J Acquir Immune Defic Syndr 1991;4:136-43.
5. Anderson W, O'Connor BB, MacGregor RR, Sanford Schwartz J. Patient use and assessment of conventional and alternative therapies for HIV infection and AIDS. AIDS 1993;7:561-6.
6. Barton SE, Jadresic DM, Hawkins DA, Gazzard BG. Complementary therapies used by people with HIV infection. AIDS 1994;8(4): 561.
7. Tilwe S. Role of alternative medicine in HIV infection [abstract PB0879]. Tenth International Conference on AIDS, Yokohana. Japan, August 1994.
8. Kabatesi D. Collaborating with traditional healers in AIDS research, prevention and care in Uganda [abstract 539B]. Tenth International Conference on AIDS, Yokohana, Japan, August 1994.
9. British Columbia Centre for Excellence in HIV/AIDS. Therapeutic guidelines for the treatment of HIV/AIDS and related conditions. British Columbia: St. Paul's Hospital, 1995.
10. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychological Measurement 1977;1(3):385-401.
11. Singh N, Squier C, Sivek C, Nguyen MH, Wagener M, Lu VL. Determinants of nontraditional therapy use in patients with HIV infection. Arch Intern Med 1996;156:197-201.
12. Market builders: new ideas help vitamin makers spur growth in the sector. Marketing 1991;96(51):1-3.
13. Rowlands C, Powderly WG. The use of alternative therapies by HIV-positive patients attending the St. Louis AIDS Clinical Trials Unit. Mo Med 1991;88:807-10.
14. Cohen CJ. Determinants of nonconventional treatment use among HIV-intected individuals [SD 781]. Sixth International Conference on AIDS, San Francisco, 1990.
15. Cassileth BR, Lusk EJ, Strouse TB, Bodenheimer BJ. Contemporary unorthodox treatments in cancer Medicine. Ann Intern Med 1984;101:105-12.
16. Langewitz W, Ruttiman S, Laifer G, Maurer P, Kiss A. The integration of alternative treatment modalities in HIV infection: the patient's perspective. J Psychosom Res 1994;38(7):687-93.
17. Archibald C, Lior L. Cumulative HIV estimates for Canada. Proceeding of the Fourth Annual HIV Epidemiology Research Meetting, Banff, Alberta, 1995.
18. Strathdee S, Schecter MT, Hogg RS, O'Shaughnessy MV. Current trends in HIV/AIDS epidemiology in British Columbia. BC Med J 1994;36:98-115.